Loading patent…
AssigneeNovartis AG
InventorsAndreas Kordikowski, Yugang Liu, Rainer Martin Lüönd, Christian Markert, Wolfgang Miltz, Till Roehn, Carsten Spanka, Gebhard Thoma, Tian XIE
Estimating the term…
The present invention provides a crystalline form of (S)-2-amino-3-(3-(4-((3-fluoro-5-(1H-pyrazol-5-yl)pyridin-2-yl)oxy)phenyl)-1H-pyrazol-1-yl)propan-1-ol, in its free form; a method for manufacturing said crystalline form, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
A crystalline form of (S)-2-amino-3-(3-(4-((3-fluoro-5-(1H-pyrazol-5-yl)pyridin-2-yl)oxy)phenyl)-1H-pyrazol-1-yl)propan-1-ol, in its free form.
Dependencies are inferred from the claim text.